$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
During embryonic development, tissue and organ morphogenesis take place through a precise program that can be described in terms of cell proliferation, cell migration and lineage specification1-4. These biological processes are also involved in maintaining adult tissue homeostasis, which requires stem cell regeneration. Lineage tracing, the identification and tracking of the progeny of a specific type of cell population, provides an important tool for studying embryogenesis and stem cell homeostasis. Indeed, it is increasingly being used in many fields of research. Particularly, lineage tracing became an essential tool in identifying the origin and fate of stem cells in homeostasis and cancer development. This is because it may provide essential information about how the cell behaves in the context of the intact tissue or organism, with minimal experimental intervention, in contrast to cell isolation and in vitro culture or transplantation that may result in unwanted bias.
Traditionally, dyes such as lipid-soluble carbocyanine, which incorporate into the plasma membrane of cells, were used for lineage tracing. Although these types of experiments have successfully led to major discoveries and shaped seminal concepts in developmental biology5,6, they have some limitations, including the difficulty to control the specificity of targeted cells, the unwanted impact of the dye on cell behavior and the dilution of the label over time. Nucleotide analogue labeling approaches have enabled documenting the existence of slow-cycling “label retaining cells” that presumably correspond to quiescent stem cells7,8. However, while this technique could demonstrate the presence of slow cycling cells based on proliferation kinetics over a limited time period it could not provide substantial insights regarding the functionality of stem cells. An optimal lineage tracing methodology should minimize the effect of labeling on the properties of the marked cell, its progeny, or its neighbors. Additionally, it would be beneficial to have control on the labeling induction, namely, to have the ability to tag the cell population of interest at a stage and time dependent manner as well as in a single cell (clonal) manner. A stable and irreversible labeling method that is passed on to all progeny of the founder cell is important so that the label would be retained over time, and not transferred to neighboring cells.
More recently, genetic approaches of cell labeling were developed. In these systems, cell specific promoters can be used to trigger Cre recombinase expression in order to remove a loxP-flanked roadblock and allow the expression of reporter genes such as green fluorescent protein or Β-galactosidase reporter genes9-13. This approach enables not only the tracking of cells and their progeny but also permits cell isolation and molecular characterization. Cell tracking at the single cell level became possible by induction of the expression of a single fluorescent reporter gene. One important limitation of this system is the fact that only when very low percentage of cells is labeled it is possible to separate and trace individual clones. To overcome this limitation multicolor reporters can be used. When using multicolor labeling, the tracking of differential fate of neighboring cells in the same niche can be achieved efficiently14-17. Recently, a variety of Brainbow (Br) alleles were developed for lineage tracing experiments, enabling a stochastic expression of multiple fluorescent reporter genes utilizing the Cre/lox system. The Cre/lox system consists of the Cre recombinase enzyme, which recognizes and binds to specific DNA sequences such as loxP sites. Following the binding of Cre recombinase, site specific recombination occurs, which causes removal of loxP flanked sequences resulting in random expression of different fluorescent proteins (the mechanism is described below). A variety of Br lines are available for use (see reviews16,18,19). The major differences between the Br strains include (i) differences in the number of fluorescent genes included in the cassette, ranging from 2 (Br 2.0), 3 (Br1.0) to 4 (Br1.1, Br2.1) fluorescent genes, (ii) the presence of reciprocally orientated lox sites to allow gene inversion (Br2.0-2.1), (iii) the type of lox sites used, and (iv) the expression or silence of fluorescent gene expression prior to Cre activation. The recently established Br3 offers an improved method for multicolor imaging of neurons. One of the main features of this transcript is that it contains a new set of photostable farnesylated fluorescent proteins, which enable an even staining of the finest neuronal processes20.
Importantly, different versions of Br cassettes may contain the neuronal specific Thy1 promoter or the ubiquitously expressed CAG (CMV) promoter. Finally, while some of the Br transgenic mice may contain a single Br transgene, others may consist of multiple transgene copies, thereby allowing the production of an immense number of possibilities for color combinations to be expressed in each cell (for example see 16).
In our study, we used the R26R-Confetti mouse which contains the Br 2.1 cassette21. Br2.1 is uniquely designed to allow Cre-mediated DNA inversions and not only excisions because of the reciprocal orientation of the loxP sites (Figure 1). Thus, these inversion/excision events which lead to color change can continue as long as Cre is present16. For that reason, an inducible temporal Cre expression system is essential for reliable cell tracking using Br2.1. As shown in Figure. 1, the Br2.1 contains a ubiquitous CAG promoter followed by loxP-flanked NeoR-cassette, which acts as a transcriptional roadblock, that is followed by 4 fluorescent reporter genes, encoding for green (GFP), yellow (YFP), red (RFP) and cyan (CFP) fluorescent proteins, positioned in two tandems. No fluorescence is expressed prior to Cre activation. Induction of Cre recombinase causes the removal of the Neo-R cassette enabling the random expression of one of the 4 fluorescent proteins in a given cell. The first segment contains loxP-flanked GFP and a reversed YFP, while the second segment contains loxP-flanked RFP and a reversed CFP. These DNA segments may continuously be inverted (using loxP that is in reversed orientation), or excised, as long as Cre recombinase is present. Therefore, a transient and controlled Cre transgene should be used. The Br2.1 cassette provides an excellent system for distinguishing between overlapping emissions upon signal location: the expression of YFP and RFP is cytoplasmic, the GFP is nuclear and the CFP is bound to the cell membrane. GFP and RFP emissions are easily separated by conventional fluorescent microscopy. In order to separate YFP/GFP/CFP emissions, a spectral confocal imaging system is needed. Altogether, the Br2.1 cassette allows the random, inducible, and tissue specific expression of one out of four distinct fluorescent genes in each targeted cell. In fact, when a larger number of color combinations is needed, one can generate homozygous mice that contain 2 alleles of Br2.1, thus resulting in the expression of 2 color tags for each cell and in raising the number of possible color combinations to 10 22. Some of the Br mouse strains enable the expression of a much greater number of possible color combinations since multiple copies of the cassette were integrated into their genome16. Yet, in most cases, the four color combinations provided by a single Br2.1 allele are sufficient. Following the protocol provided here, one can establish this method using a relatively simple setup of spectral microscopy with little if any need for calibration.
Here we provide an adaptable protocol for the use of the R26R-Confetti mice that contain a single Br2.1 allele, for lineage tracing experiments of the corneal epithelium. This transgenic mouse strain has been used for studying the origin and fate of colon 21,23 and corneal epithelial stem cells22,24, the presence of stem cell activity in intestinal cancer25, and for characterizing kidney podocyte in focal segmental glomerulosclerosis (FSGS)17.